招募
发表于 2025-3-27 00:49:51
https://doi.org/10.1007/978-3-322-80961-2keletal muscle due to interference with neuromuscular transmission by antibodies to acetylcholine receptors (AChR). Circulating polyclonal anti-AChR antibodies can be demonstrated in nearly 90% of patients with generalized MG .
滑动
发表于 2025-3-27 03:39:55
Einleitung: Regieren mit der Mediation,d in the presence of a characteristic skin rash. Cardiac involvement may occur, and certain cases of idiopathic cardiomyopathy without skeletal muscle disease may constitute a separate entity within the group of immunologically mediated myopathies.
Offstage
发表于 2025-3-27 07:37:33
https://doi.org/10.1007/978-3-642-70607-3autoimmune disease; diseases; research
不幸的人
发表于 2025-3-27 12:53:05
978-3-642-70609-7Sandoz Ltd, Basle and Springer-Verlag Berlin Heidelberg 1985
Anticlimax
发表于 2025-3-27 15:28:58
Studien zur politischen GesellschaftMyasthenia gravis (MG) is a humorally mediated autoimmune disease. Circulating autoantibodies (ab) against the postsynaptic acetylcholine receptor (ACHR) are responsible for the postsynaptic transmission failure which is the cause of the abnormal weakness and fatigability of the skeletal muscles in myasthenics .
听写
发表于 2025-3-27 19:32:35
Ciclosporin (CyA) in Myasthenia GravisMyasthenia gravis (MG) is a humorally mediated autoimmune disease. Circulating autoantibodies (ab) against the postsynaptic acetylcholine receptor (ACHR) are responsible for the postsynaptic transmission failure which is the cause of the abnormal weakness and fatigability of the skeletal muscles in myasthenics .
allergen
发表于 2025-3-28 01:36:29
Preface to CyA Proceedingssms of action it was self-evident that the new substance should be tested also in the wide field of autoimmune diseases. With this volume an attempt has been made to provide full information to the scientific community about the status of ciclosporin as a possible treatment in these indications.
Eviction
发表于 2025-3-28 02:52:40
http://reply.papertrans.cn/23/2266/226521/226521_38.png
多样
发表于 2025-3-28 09:49:40
http://reply.papertrans.cn/23/2266/226521/226521_39.png
滴注
发表于 2025-3-28 11:13:09
http://reply.papertrans.cn/23/2266/226521/226521_40.png